Phoenix doctors received a total of $26.5 million in non-research payments from drug and device companies in 2015, according to data collected from the U.S. Centers for Medicare and Medicaid Services.
These payments include royalties, licensing fees, speaking fees, and travel and lodging reimbursements.
As a result of the Affordable Care Act, this is the third year CMS has made public Open Payments data, also known as the Sunshine Act, shedding light on financial relationships between health care…
Phoenix doctors received a total of $26.5 million in non-research payments from drug and device companies in 2015, according to data collected from the U.S. Centers for Medicare and Medicaid Services.
These payments include royalties, licensing fees, speaking fees, and travel and lodging reimbursements.
As a result of the Affordable Care Act, this is the third year CMS has made public Open Payments data, also known as the Sunshine Act, shedding light on financial relationships between health care…